Therapeutics: Glycogen synthase kinase 3 β (GSK3B)

In vitro and mouse studies identified an ATP-competitive GSK3B inhibitor that could help treat bipolar disorder. Chemical synthesis and in vitro testing of 1H-indazole-3-carboxamide analogs identified...